Clinical Trial Update: Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating valproic acid in combination with cisplatin and cetuximab for recurrent or metastatic squamous cell carcinoma of the head and neck (SCC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: UNKNOWN